We are excited to share the latest work from our MESOMICS project in which we disentangle the molecular, clinical and morphological heterogeneity of malignant pleural mesothelioma (MPM) using deep integrative omics analyses: https://biorxiv.org/cgi/content/short/2021.09.27.461908v1. MPM is a rare aggressive cancer associated with asbestos exposure. In the past decade, knowledge on the molecular profile of MPM has

This is a great opportunity to start collaborations that will help translate our molecular data into clinical practice.

Lynnette Fernandez-Cuesta had the honor to participate as expert co-author for Neuroendocrine Tumors chapter. It can be found here.

Emilie Mathian gave an oral talk entitled “A molecular map of lung neuroendocrine neoplasms” at the 2021 Virtual 18th Annual ENETS Conference.

Check out our review in Virchows Archiv entitled “Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas” Full paper can be found here.

Check out our recent published paper on GigaScience: A molecular map of lung neuroendocrine neoplasms. Full paper can be found here. We invite you also to read the Q&A with Matthieu Foll about Accessing and reviewing Controlled Access Data of Rare Cancers.

Lynnette Fernandez Cuesta and Matthieu Foll presented the Rare Cancer Genomics initiative at the International Symposium on Human Genomics – February 10-12, 2020 in Paris (France)

EBioMedicine journal’s website https://www.ebiomedicine.com/article/S2352-3964(19)30601-2/fulltext and ScienceDirect https://www.sciencedirect.com/science/article/pii/S2352396419306012.

https://tumormap.ucsc.edu